e-learning
resources
London 2016
Monday, 05.09.2016
Endoscopic lung volume reduction II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Segmental lung volume reduction (LVR) with vapor better targets disease heterogeneity as compared to lobar LVR
Wolfgang Gesierich (Gauting, Germany), Wolfgang Gesierich, Uta Liebers, Manfred Wagner, Joachim H. Ficker, Christian Grah, Greg Snell
Source:
International Congress 2016 – Endoscopic lung volume reduction II
Session:
Endoscopic lung volume reduction II
Session type:
Poster Discussion
Number:
1856
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wolfgang Gesierich (Gauting, Germany), Wolfgang Gesierich, Uta Liebers, Manfred Wagner, Joachim H. Ficker, Christian Grah, Greg Snell. Segmental lung volume reduction (LVR) with vapor better targets disease heterogeneity as compared to lobar LVR. Eur Respir J 2016; 48: Suppl. 60, 1856
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Endoscopic lung volume reduction (ELVR) in COPD: Improvements in gas transfer capacity correlate with improvements in ventilation and perfusion (VQ) matching
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
CT assessment of lobar heterogenity and fissure integrity in pulmonary emphysema for bronchoscopic lung volume reduction with valve
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015
Echocardiogram parameters in patients with COPD in the year after endoscopic lung volume reduction (ELVR)
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015
Volume changes after segmental vapor ablation and associated improvements in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
The minimal important difference for target lobe volume reduction following endoscopic valve therapy in patients with advanced emphysema
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Endoscopic lung volume reduction in low FEV1 patients
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Bronchoscopic lung volume reduction with endobronchial valves improves exercise capacity but not oxygen uptake kinetics in a group of patients with severe emphysema
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
Endoscopic lung volume reduction (ELVR) in COPD: A comparison between two endobronchial valves systems
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Role of quantitative perfusion scintigraphy evaluation in determination of the efficiency of the procedure before lung volume reduction coil (LVRC) treatment for severe emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Lobar variation of emphysema impacts lung function
Source: International Congress 2015 – A more functional view of chest pathology
Year: 2015
Lung volume reduction coil (LVRC) treatment is safe and effective in heterogeneous and homogeneous emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Impact of atelectasis on survival in emphysema patients treated with bronchoscopic lung volume reduction
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Quantitative CT (QCT) analysis of emphysema and air trapping in coil-based lung volume reduction (LVRC) treatment
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016
A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Histology of arteriolar wall remodelling in a lung volume reduction surgery (LVRS) patient cohort
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
Endoscopic lung volume reduction in high risk patients with FEV1≤20%
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept